Indivior News and Activities

Presence

Indivior develops and sells medicines for opioid use disorder and serious mental health conditions. Its products and support services serve patients, healthcare professionals, treatment providers, and public health systems.

Indivior products and services overview:

Addiction treatment
Mental health medicines
Prescription therapies
Patient support services

Revenue: ~$1 billion

Employees: 1,100

Headquarters: Slough, United Kingdom (UK)

Indivior is owned by Reckitt Benckiser.

Reckitt Benckiser is one of the...

Reckitt Benckiser is a company listed under the stock ticker RB (GB).

Reckitt Benckiser has a direct presence in 10 countries.

Reckitt Benckiser has 11 subsidiaries including Indivior, Reckitt Benckiser ANZ and Reckitt Benckiser Canada.

They are in:

Household Products92%
Pharmaceuticals8%

Executives

View the org chart displaying its 38 main executives

Most searched biographies at Indivior

Popular executive movements at Reckitt Benckiser

Fiona Dawson, Non-Executive Director and Chair Designate for the Remuneration Committee, has left the company (posted on May 26 2026).
Harry Kirsch has joined the company as Non-Executive Director (posted on May 18 2026).
David Croft, Global Head of Sustainability, has left the company (posted on May 18 2026).

Click here to view some more movements at Reckitt Benckiser

Create your alert
to follow the executive moves at Indivior.